Ledger.Open graph →
SEC Form D · filed August 9, 2011

Genesis Biopharma, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
—
Industry
Biotechnology
Location
LOS ANGELES, CA
Type
—

People & firms on this filing (8)

Michael Handelman · Los Angeles, CAExec · DirectorAnthony Cataldo · Los Angeles, CAExec · DirectorMichael Handelman · Beverly Hills, CAExec · DirectorDr. L. S. Coles · Los Angeles, CADirectorDr. William Andrews · Los Angeles, CADirectorMerrill A. Mcpeak · Cranbury, NJDirectorMartin Schroeder · LOS ANGELES, CADirectorDavid Voyticky · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗